Active

Drug Development Program

Alzheimer's Drug Discovery Foundation

Sponsor Website

View in Pivot

DEADLINE

Sep 14, 2026Confirmed

AMOUNT

Up to $5M

CAREER STAGE

Early Career and Emerging in Field Mid-Career to Established in Field

RESEARCH AREAS

Alzheimers Disease Cardiology Drug Design Epigenetics Geriatrics & Gerontology Inflammation Metabolites Nervous System Neurotransmitters Pharmacokinetics Pharmacotherapy Pharmacy & Pharmacology Psychology of Aging

OPPORTUNITY SUMMARY

Supports IND-enabling studies and early-phase clinical trials for innovative pharmacological interventions and devices targeting Alzheimer’s disease and related dementias. Focus areas include combination therapies, disease-modifying agents, symptomatic treatments, aging biology, and emerging therapeutic mechanisms. Emphasizes diverse drug designs and modes of action.

ELIGIBILITY

Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged. Biotechnology companies. Existing companies and new startups are both eligible.

FUNDING INFORMATION

Amount Upper: $5,000,000 USD Amount Note: Award Amount Up to $5,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment. Average Duration Multi-year Allowable costs Only direct costs are allowed.